6 November, 2015
Skadden is acting as U.S. legal advisor to the buyer group in the going-private transaction of Mindray Medical International Limited (NYSE: MR). The buyer group is composed of Mr. Xiting Li, the executive chairman, president and co-chief executive officer, Mr. Hang Xu, the chairman of the board, and Mr. Minghe Cheng, the co-chief executive officer and chief strategic officer of Mindray Medical. The transaction, which values the company at approximately US$3.3 billion, was announced November 4.
Mindray Medical is a leading developer, manufacturer and marketer of medical devices globally and supports its worldwide distribution network with a broad range of products across three primary business segments, namely patient monitoring and life support, in-vitro diagnostics, and medical imaging systems.
The Skadden team includes, in Beijing and Hong Kong, Peter Huang, Andre Zhu, Yeping Huang, Ning Dong and Chunbei Li, corporate; and Clive Rough and Yin Lin Ma, banking.
